drugset / Trial / NCT00362661

Low-dose Cortisol in Chronic Posttraumatic Stress Disorder

NCT00362661

Terminated 20 enrolled University of Zurich
RandomizedCrossoverQuadruple-blindTreatment

Summary

The aim of this prospective, double-blind, placebo-controlled, cross-over study is to determine the therapeutic efficacy of low-dose cortisol for symptoms of chronic posttraumatic stress disorder.

Timeline

Start
2007-06
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocortisone Other / unclassified 10 mg